The FDA issued a warning letter to Novo Nordisk, the Danish drugmaker behind the diabetes and weight-loss medications Ozempic and Wegovy, over unreported potential side effects.
FDA warns Novo Nordisk over unreported potential Ozempic side effects
Mar 10, 2026 | 1:50 PM
